Today in Science
SEE OTHER BRANDS

Fresh science news from the world

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on May 28, 2025

Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress

Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress

SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular …

Hi-View Announces Non-Brokered Private Placement

Hi-View Announces Non-Brokered Private Placement

VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- HI-VIEW RESOURCES INC. (‘HI-VIEW' OR THE ‘COMPANY’) (CSE: HVW; OTCQB: HVWRF; FSE: B63) announces a non-brokered private placement of up to 4,800,000 units (each a “Unit”) at a price of $0.10 per …

Kneat Announces Results of Voting at Annual General Meeting

Kneat Announces Results of Voting at Annual General Meeting

LIMERICK, Ireland, May 28, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTC: KSIOF) ("Kneat" or the "Company") a leader in digitizing and automating validation processes, announced results from its Annual General Meeting of Shareholders (the "2025 …

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2nd • Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER PARK …

Astrotech Corporation Appoints Jennifer Cañas as Chief Financial Officer

Astrotech Corporation Appoints Jennifer Cañas as Chief Financial Officer

AUSTIN, Texas, May 28, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or (“Astrotech”), today announced that it has appointed Jennifer Cañas as Chief Financial Officer (“CFO”) of the Company. Ms. Cañas’ appointment is …

IMUNON Closes Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules

IMUNON Closes Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants LAWRENCEVILLE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company …

B2Gold Releases its Ninth Annual Responsible Mining Report and its Fourth Annual Climate Strategy Report

B2Gold Releases its Ninth Annual Responsible Mining Report and its Fourth Annual Climate Strategy Report

VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO) (NYSE AMERICAN: BTG) (NSX: B2G) (“B2Gold” or the “Company”) is pleased to announce that it has published its ninth annual Responsible Mining Report entitled “Raising the …

Golconda Gold Ltd. Releases Financial and Operating Results for Q1 2025

Golconda Gold Ltd. Releases Financial and Operating Results for Q1 2025

TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Golconda Gold Ltd. (“Golconda Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) is pleased to announce the release of its financial and operating results for the three months ended March 31, 2025. A copy of the …

Quorum Announces Q1 2025 Results and Board Changes

Quorum Announces Q1 2025 Results and Board Changes

CALGARY, Alberta, May 28, 2025 (GLOBE NEWSWIRE) -- Quorum Information Technologies Inc. (TSX-V: QIS) (“Quorum”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original Equipment …

JetStor Unveils Infinite: The World’s First Data Platform as a Service (DPaaS) Revolutionizing Enterprise Storage

JetStor Unveils Infinite: The World’s First Data Platform as a Service (DPaaS) Revolutionizing Enterprise Storage

PITTSBURGH, May 28, 2025 (GLOBE NEWSWIRE) -- JetStor, a pioneer in high-performance data storage, today launched JetStor Infinite, the industry’s first Data Platform as a Service (DPaaS). By unifying direct-attached storage (DAS), network-attached storage …

Gentherm Announces Participation in Upcoming Second Quarter 2025 Investor Conferences

Gentherm Announces Participation in Upcoming Second Quarter 2025 Investor Conferences

NOVI, Mich., May 28, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the following upcoming investor events …

Healios K.K. to Present at the 2025 Jefferies Global Healthcare Conference

Healios K.K. to Present at the 2025 Jefferies Global Healthcare Conference

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows: Date …

Tour of De Havilland Canada’s Special Mission Aircraft

Tour of De Havilland Canada’s Special Mission Aircraft

OTTAWA, Ontario, May 28, 2025 (GLOBE NEWSWIRE) -- Members of the media are invited to attend the Skyservice Business Aviation Hangar at the Ottawa airport for a tour of De Havilland Canada’s Special Mission Aircraft. The event will include a walk-through …

NVIDIA Announces Financial Results for First Quarter Fiscal 2026

NVIDIA Announces Financial Results for First Quarter Fiscal 2026

Revenue of $44.1 billion, up 12% from Q4 and up 69% from a year ago Data Center revenue of $39.1 billion, up 10% from Q4 and up 73% from a year ago SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- NVIDIA (NASDAQ: NVDA) today reported revenue for the …

HP Inc. Reports Fiscal 2025 Second Quarter Results

HP Inc. Reports Fiscal 2025 Second Quarter Results

PALO ALTO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- HP (NYSE: HPQ) Second quarter GAAP diluted net earnings per share ("EPS") of $0.42, down 31% from the prior year period Second quarter non-GAAP diluted net EPS of $0.71, down 13% from the prior year …

CoreMap, Inc. Receives U.S. FDA Investigational Device Exemption (IDE) Approval for INvENI Map-Guided AF Ablation Study

CoreMap, Inc. Receives U.S. FDA Investigational Device Exemption (IDE) Approval for INvENI Map-Guided AF Ablation Study

BURLINGTON, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- CoreMap today announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to extend the INvENI clinical study into the U.S. This study is …

Supernus Announces Paragraph IV ANDA Filings for Qelbree®

Supernus Announces Paragraph IV ANDA Filings for Qelbree®

ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …

Supernus to Participate in the 2025 Jefferies Global Healthcare Conference

Supernus to Participate in the 2025 Jefferies Global Healthcare Conference

ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that …

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Goldman Sachs …

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service